Publication in “Oncotarget” : “CXXC5 is a Potential Therapeutic Target in High-Risk Human Acute Myeloid Leukemia.”

“CXXC5 (Retinoid-Inducible Nuclear Factor, RINF) is a Potential Therapeutic Target in High-Risk Human Acute Myeloid Leukemia.”

Astori A, Fredly H, Aloysius TA, Bullinger L, Mas VM, de la Grange P, Delhommeau F, Hagen KM, RĂ©cher C, Dusanter-Fourt I, Knappskog S, Lillehaug JR, Pendino F, Bruserud O, Oncotarget, 2013 Aug.

Pubmed

This entry was posted in Article. Bookmark the permalink.

Comments are closed.